Skip to main content
Erschienen in: Clinical Neuroradiology 1/2023

Open Access 24.06.2022 | Original Article

Meniscus Sign in Patients with Anterior Circulation Large Vessel Occlusion Stroke does not Predict Outcome

verfasst von: André Miranda, Ramy Abdelnaby, André Araújo, Marta Rodrigues, Valeria Battistella, José Mário Roriz, Carmélia Rodrigues, Martin Wiesmann, Jörg B. Schulz, Omid Nikoubashman, Arno Reich, Manuel Ribeiro, João Pinho

Erschienen in: Clinical Neuroradiology | Ausgabe 1/2023

Abstract

Purpose

The angiographic appearance of the occlusion site was suggested to influence outcomes of stroke patients with large vessel occlusion (LVO) who undergo endovascular treatment (EVT). We aimed to study the impact of the meniscus sign (MS) on outcomes of stroke patients with anterior circulation LVO.

Methods

Based on two prospective registries of acute ischemic stroke, we selected patients with carotid‑T, M1 or M2 occlusion who underwent EVT. Clinical characteristics and outcomes were collected from the registries or from individual records. Two independent observers blinded to outcomes assessed the presence of MS in digital subtraction angiography before thrombectomy. Angiographic and clinical outcomes of patients with and without MS were compared.

Results

We included 903 patients, with median age of 78 years, 59.8% were male, median baseline NIHSS was 14 and 39.5% received intravenous thrombolysis. Patients with MS (n = 170, 18.8%) were more frequently female, presented with higher NIHSS scores and more frequently underwent intravenous thrombolysis. Presence of MS was significantly associated with cardioembolic etiology. Successful reperfusion, number of passes, first pass effect, procedural time, symptomatic intracerebral hemorrhage, in-hospital mortality and favorable 3‑month functional outcome were similar in the groups of patients with and without MS. In the multivariable analyses, MS was not associated with successful reperfusion (odds ratio, OR = 1.08, 95% confidence interval, CI = 0.76–1.55), first pass effect (OR = 0.96, 95%CI = 0.48–1.92) or favorable 3‑month outcome (OR = 1.40, 95%CI = 0.88–2.24).

Conclusion

The presence of MS in acute ischemic stroke patients with anterior circulation large vessel occlusion who undergo EVT does not appear to influence angiographic or clinical outcomes.

Introduction

Advances in the techniques and devices used in endovascular treatment (EVT) of acute ischemic stroke patients with large vessel occlusion have led to significant improvements in angiographic and clinical outcomes in the last 20 years [1]. In addition to technical aspects of EVT, there are also several patient-related factors that appear to influence the technical success of EVT and, consequently, may influence clinical outcomes. Factors such as vessel anatomy with increased curvature [2], increased clot burden score [3], thrombus imperviousness [4] and non-cardioembolic stroke etiology [5] have been associated with decreased reperfusion rates of EVT and/or poorer functional outcome. There are also some studies which suggest that the angiographic appearance of the occlusion site may also influence the reperfusion rates and clinical outcomes [6]. The meniscus sign is an angiographic sign with a concave appearance of the distal contrast column in the occlusion site, which has been associated not only with better reperfusion rates but also with fewer passes, shorter procedure time and better functional outcome [7, 8]; however, the significance of the meniscus sign in this setting remains unclear, because the few studies analyzing the meniscus sign were monocentric studies with small population sizes.
Our aim was to analyze the impact of meniscus sign in angiographic and clinical outcomes in patients with acute ischemic stroke with anterior circulation large vessel occlusion submitted to EVT.

Methods

We conducted a multicentric retrospective case-control study based on prospective local registries of consecutive acute ischemic stroke patients submitted to EVT in two high volume comprehensive stroke centers during a 3-year period (July 2018–June 2021). Management protocols of acute ischemic stroke patients in both centers follow national and international recommendations [9]. Both centers use mainly a stent-retriever technique with femoral artery access as the technique of choice for the treatment of patients with large vessel occlusion. The combined stent-retriever-assisted vacuum-locked extraction technique was routinely used in one center. Only a residual proportion of patients (< 5%) are treated using the contact aspiration technique as the method of first choice. Balloon-guided catheters with proximal flow control are routinely used in both centers. In both centers, however, the choice of the technique is to the discretion of the interventionalist according to the anatomic and clinical characteristics of individual patients. Inclusion criteria were: 1) adult patients admitted for acute ischemic stroke; 2) presence of large vessel occlusion of the anterior circulation (carotid T, M1, M2) and 3) patients submitted to EVT. Exclusion criteria were: 1) occlusion of the cervical internal carotid artery; 2) tandem occlusion; 3) EVT other than mechanical thrombectomy, namely isolated intra-arterial thrombolysis or isolated stenting; 4) unavailability of the digital subtraction angiography (DSA) images for review. Baseline demographic variables, clinical variables, treatment with intravenous thrombolysis, details and time metrics of EVT and 3‑month outcome were collected from the prospective registries or directly from individual patient records when the information was not available in the registry. Information on ethnicity and cultural background was not available for collection, but the included patients stem from populations where west Europeans represent the largest ethnic and cultural group. Successful reperfusion was defined as a revised thrombolysis in cerebral infarction (TICI) of 2b, 2c or 3, and complete reperfusion was defined as TICI 3 [10]. First pass effect was defined as achievement of TICI 2c or 3 after the first thrombectomy maneuver. Procedural time was defined as the time between the arterial puncture and achievement of the best reperfusion, or the end of the procedure in case of persistent occlusion. Symptomatic intracerebral hemorrhage (sICH) was defined as an ICH occurring within 48 h after EVT and associated with an increase of ≥ 4 points in the National Institutes of Health Stroke Scale (NIHSS). Stroke etiology was defined according to the criteria used in the ASCOD classification [11] and published criteria for embolic stroke of undetermined source (ESUS) [12]. Favorable 3‑month outcome was defined as a modified Rankin scale (mRS) of 0–2 and collected from the prospective registries. Assessment of 3‑month functional outcome is carried out routinely in the outpatient clinic or through telephone interview in both centers.

Assessment of Angiographic Clot Occlusion Signs

Diagnostic DSA image series before any mechanical thrombectomy maneuver were reviewed by two independent experienced observers in each center, who were blinded to patient characteristics, angiographic and clinical outcomes. Both anteroposterior and mediolateral image perspectives were systematically analyzed. The presence of meniscus sign was defined as the presence of a concave appearance of the distal contrast column in the occlusion site (Fig. 1). The tram-track sign (Supplementary Fig. 1) was also assessed because it has been considered as equivalent to the meniscus sign in some studies [7, 8]. Tram-track sign was defined as one or two-wall elongated opacification of the vessel distal to the central contrast column. Disagreements between observers were settled by consensus after joint review of the DSA images.

Statistical Analyses

Baseline characteristics of patients with and without meniscus sign were compared using χ2-tests and Mann-Whitney U-tests as appropriate. Distribution of continuous variables was analyzed using the Shapiro-Wilk test. The predictive role of meniscus sign for successful reperfusion, first pass effect and favorable 3‑month outcome was examined using univariable and single-step multivariable logistic regression analyses, odds ratios (OR) and corresponding 95% confidence intervals (95% CI) were calculated. Variables thought a priori to possibly influence angiographic outcomes were included as covariates in the multivariable logistic regression model (age, sex, baseline NIHSS, intravenous thrombolysis, cardioembolic etiology). Variables thought a priori to influence clinical outcomes were included as covariates in the multivariable logistic regression model (age, sex, baseline NIHSS, baseline Alberta Stroke Program Early Computed Tomography Score, occlusion of carotid‑T, intravenous thrombolysis, sICH, cardioembolic etiology). Sensitivity analyses using the presence of meniscus and tram-track signs were also performed. Post hoc diagnostic performance analysis and univariable and single-step multivariable logistic regression analyses for the association of the meniscus sign with cardioembolic etiology were carried out. The threshold for statistical significance was set at an alpha level of 0.05. All statistical analyses were conducted using STATA version 17.0 (StataCorp LLC, College Station, TX, USA).
Retrospective studies based on the local registry of patients with acute ischemic stroke were approved by the local ethics committees (approval references 335/15 and 151/21) and, because of the retrospective nature, the ethics committees waived the need for patient-signed consent. This report follows the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines [13].
This study provides class II evidence for the significance of the angiographic meniscus sign as a marker for angiographic and clinical outcomes.

Data Availability

Anonymized data may be provided by the corresponding author upon reasonable request for research purposes and according to the recommendations of the local ethics committees.

Results

From a total of 1499 acute ischemic stroke patients submitted to EVT during the study period, we excluded: 197 patients because of occlusion of arteries other than those defined in the inclusion criteria, 139 patients because of tandem occlusion, 93 patients because of absent diagnostic digital subtraction angiography images, 78 patients because of isolated cervical carotid artery, 49 patients because of reperfusion after thrombolysis and 40 patients because of endovascular treatment other than mechanical thrombectomy (Supplementary Fig. 2). The final study population consisted of 903 patients, with a median age of 78 years (interquartile range, IQR = 67–85), 59.8% were male, baseline NIHSS was 14 (IQR = 9–18) and 39.5% received intravenous thrombolysis. Endovascular treatment using stent-retriever was performed in the vast majority of patients (96.8%) and successful reperfusion was achieved in 92.7% of patients. Information on functional status 3 months after stroke was available for 680 patients, and favorable outcome was achieved in 42.8%. Interobserver agreement for the presence of meniscus sign was substantial (κ = 0.76).
Meniscus sign was present in 170 patients (18.8%). Table 1 describes the baseline characteristics of patients with and without meniscus sign. Patients with meniscus sign were more frequently female (67.7% versus 58.0%, p = 0.021), had slightly higher NIHSS (15 versus 14, p = 0.043) and had been treated more frequently with intravenous thrombolysis (48.8% versus 37.4%, p = 0.006). Patients with meniscus sign had more frequently a cardioembolic etiology for stroke (76.0% versus 65.0%, p = 0.008) and less frequently had intracranial stenosis at the site of occlusion (0.6% versus 6.4%, p = 0.003). The association of meniscus sign and cardioembolic etiology persisted after adjustment for relevant confounders (Supplementary Table 1). The meniscus sign presented a sensitivity of 21.3%, a specificity of 86.3%, a positive predictive value of 75.9% and a negative predictive value of 35.0% for the presence of cardioembolic etiology.
Table 1
Characteristics of the study population according to the presence of the meniscus sign
 
No meniscus sign (n = 733)
Meniscus sign
(n = 170)
p
Male sex
308 (42.0)
55 (32.3)
0.021
Age (years)
78 (67–85)
79 (71–84)
0.346
Hypertension
537 (73.4)
131 (77.1)
0.322
Diabetes
183 (25.0)
38 (22.4)
0.470
Dyslipidemia
281 (38.3)
59 (34.7)
0.379
Baseline anticoagulation
181 (24.7)
36 (21.2)
0.334
Intravenous thrombolysis
274 (37.4)
83 (48.8)
0.006
Baseline NIHSS score
14 (9–18)
15 (10–19)
0.043
Baseline ASPECTS score
9 (8–10)
9 (7–10)
0.477
Large vessel occlusion site
0.307
Carotid T
109 (14.9)
33 (19.4)
M1
387 (52.8)
82 (48.2)
M2
237 (32.3)
55 (32.4)
Onset-to-groin puncture time (minutes)
224 (150–405)
234 (146–372)
0.964
Ischemic stroke etiology a
Cardioembolic
444 (65.0)
120 (76.0)
0.008
Cervical large vessel disease
31 (4.5)
5 (3.2)
0.442
Intracranial stenosis
44 (6.4)
1 (0.6)
0.003
Dissection
7 (1.0)
0
0.201
ESUS
135 (19.8)
30 (19.0)
0.824
Other cause
22 (3.2)
2 (1.3)
0.183
Values are presented as n (%) or median (interquartile range)
NIHSS National Institutes of Health Stroke Scale, ESUS embolic stroke of undetermined source, ASPECTS Alberta Stroke Program Early Computed Tomography Score
a Missing etiology in 62 patients because of incomplete investigation
The angiographic outcomes between the two groups did not differ significantly (Table 2). Achievement of successful reperfusion, complete reperfusion, number of passes, and first pass effect were similar in patients with and without meniscus sign. There was a nonsignificant trend for slightly faster procedural times in patients with meniscus sign (median time 33 min vs. 40 min, p = 0.092). The site of the occlusion did not influence successful reperfusion, complete reperfusion, first pass effect, number of passes or procedural time in patients with and without meniscus sign (Supplementary Table 2). Likewise, we found no difference in periprocedural complications, in the occurrence of sICH or in-hospital mortality. The 3‑month favorable outcome was similar in both groups (Table 2).
Table 2
Angiographic and clinical outcomes according to the presence of the meniscus sign
 
No meniscus sign
(n = 733)
Meniscus sign
(n = 170)
p
Angiographic outcomes
Number of passes
1 (1–2)
1 (1–2)
0.645
Number of passes ≥3
171 (23.3)
35 (20.6)
0.443
First pass effect
338 (46.1)
85 (50.0)
0.360
Successful reperfusion
679 (92.6)
158 (92.9)
0.889
Complete reperfusion
462 (63.0)
110 (64.7)
0.683
Procedural time (min)
40 (24–66)
33 (23–55)
0.092
Periprocedural complications
0.165
Arterial perforation
12 (1.7)
2 (1.2)
Embolization to different territory
5 (0.7)
4 (2.4)
Dissection
22 (3.0)
8 (4.7)
Clinical outcomes
Symptomatic intracerebral hemorrhage
43 (5.9)
12 (7.1)
0.558
In-hospital mortality
110 (15.0)
22 (12.9)
0.492
Favorable 3‑month outcome a
228 (41.5)
63 (48.1)
0.173
Values are presented as n (%) or median (interquartile range)
a 3-month functional status available for 680 patients
In the univariable logistic regression analysis presence of meniscus sign was not associated with first pass effect, with successful reperfusion or with favorable 3‑month outcome. Presence of meniscus sign was also not associated with first pass effect, successful reperfusion or favorable 3‑month outcome in the multivariable logistics regression analyses (Table 3). When patients with meniscus sign and with tram-track sign were analyzed as one group, the angiographic and clinical outcome results did not change significantly comparing to the analyses of patients with meniscus sign only (Supplementary Tables 3 and 4).
Table 3
Univariable and multivariable logistic regression analyses for meniscus sign as a predictor of successful reperfusion and first pass effect
 
Odds ratio
(95% confidence interval)
p
Successful reperfusion
Meniscus sign (unadjusted)
1.17 (0.84–1.63)
0.360
Meniscus sign (adjusted) a
1.08 (0.76–1.55)
0.657
First pass effect
Meniscus sign (unadjusted)
1.04 (0.55–2.00)
0.889
Meniscus sign (adjusted) a
0.96 (0.48–1.92)
0.898
Favorable 3‑month outcome
Meniscus sign (unadjusted)
1.30 (0.89–1.91)
0.173
Meniscus sign (adjusted) b
1.40 (0.88–2.24)
0.159
a Adjustment for age, sex, baseline National Institutes of Health Stroke Scale, intravenous thrombolysis, cardioembolic etiology
b Adjustment for age, sex, baseline National Institutes of Health Stroke Scale, baseline Alberta Stroke Program Early Computed Tomography Score, occlusion of carotid‑T, intravenous thrombolysis, symptomatic intracerebral hemorrhage, cardioembolic etiology.

Discussion

The main conclusion of our study is that the meniscus sign does not influence angiographic outcomes and is not a predictor of clinical outcomes in acute ischemic stroke patients with anterior circulation large vessel occlusion who receive EVT. The presence of meniscus sign in DSA before mechanical thrombectomy was not associated with achievement of successful reperfusion, complete reperfusion first pass effect or number of passages, and we only found a nonsignificant trend for slightly longer procedural times in these patients. The presence of the meniscus sign was also not associated with angiographic outcomes when different arterial occlusion sites (carotid T, M1, M2) were individually analyzed. In addition, no association of meniscus sign and periprocedural complications, sICH, intrahospital mortality or favorable 3‑month functional outcome was found. Our results confirm a high angiographic efficacy of EVT in a real-world setting, which is probably a result of a continuous improvement of techniques and devices and may render irrelevant the angiographic appearance of occlusion site.
The current limited available evidence suggested, however, an association between the presence of the meniscus sign and better outcomes. In a cohort of 89 patients with basilar artery occlusion, the meniscus sign, which occurred more frequently in distal occlusions, was found to be an independent predictor of successful reperfusion, and was associated with shorter procedural times, higher incidence of first pass effect and lower number of passes [7]. Specific characteristics of the basilar artery occlusions may mediate these findings, namely higher frequency of underlying large vessel disease and need for intracranial stenting [14]. We found that the meniscus sign was rare in the presence of underlying intracranial stenosis and is significantly associated with cardioembolic etiology, which is a known independent predictor of successful reperfusion [5]. In cohorts where the proportion of intracranial atherosclerotic stenosis is higher, such as in Asian stroke patients [15], a significant proportion of patients with large vessel occlusion and no meniscus sign will have an in situ thrombosis in an intracranial atherosclerotic plaque and/or stenosis, which may be associated with reduced efficacy of EVT [16]. Likewise, lower reperfusion rates are expected to be achieved in patients with basilar artery occlusion and no meniscus sign, because a high proportion of these patients will present a severe basilar artery stenosis, which is known to be responsible for 1/4 of basilar artery occlusion cases [17]. We emphasize that our results are, therefore, mainly valid for occlusions of the anterior circulation and for west European populations.
Another study which analyzed the angiographic appearance of the occlusion site in patients with M1 or M2 occlusion who received EVT showed that the presence of the meniscus and the tram-track signs was associated with a lower number of passes and with better 3‑month functional outcome [8]. This study is, however, limited because of the small size of the study population (144 patients included of whom only 18 presented meniscus or tram-track sign).
Other smaller studies also examined the significance of angiographic occlusive signs in patients with large vessel occlusion who underwent EVT; however, a specific evaluation of the meniscus sign was not performed [18, 19]. Although a higher prevalence of the meniscus sign was reported in patients with basilar artery occlusion (63%) [7], the prevalence of 19% we found in the anterior circulation is more in line with the prevalence of 13% and 34% found by Mönch et al. [8] and Garcia-Bermejo et al. [19], respectively. These three studies had significantly smaller study populations in comparison to our study, but the prevalence of meniscus sign will probably vary according to the territory of the occlusion and to the relative distribution of different stroke etiologies in each study.
In an older study of 33 patients treated with intra-arterial thrombolysis, the presence of meniscus sign (found in 6 patients) required lower doses of urokinase for achievement of reperfusion and was associated with higher rates of at least partial reperfusion [20]. The reason for patients who received intravenous thrombolysis to have more frequently meniscus sign in our study remains unclear. We excluded a possible effect of time between symptom onset and groin puncture in the presence of meniscus sign. If it could represent a sign for a higher thrombus susceptibility to thrombolysis remains speculative. A possible link supporting this hypothesis is that thrombi with cardioembolic origin, usually rich in fibrin and platelets, also have an increased perviousness in computed tomography [21], which is known to be associated with higher success of intravenous thrombolysis [22]. Although, in our study, the meniscus sign was more frequent in patients with cardioembolic stroke etiology, studies report conflicting results in what the association between meniscus sign and thrombus perviousness is concerned [8, 23].
The independent association of the meniscus sign with cardioembolic etiology was not previously reported in the literature, even though Garcia-Bermejo et al. described a higher frequency of cardioembolic etiology in patients with non-tapered occlusions (which include the meniscus sign) [19]. Even though specificity was relatively high, the diagnostic performance of the meniscus sign for the presence of underlying cardioembolic etiology was not optimal; however, the aim of our study was not to specifically address biomarkers for cardioembolism. The likelihood of an underlying intracranial stenosis appears to be low in the presence of the meniscus sign, unlike the taper sign (beak-like or flame-like occlusion appearance), which has been associated with intracranial atherosclerotic lesions and dissections [6]. These associations between the angiographic appearance of the occlusion site and stroke etiology must be interpreted with caution and confirmed in independent cohorts with adjustment for other important variables which were not evaluated in our study.
The reasons for the associations we found between meniscus sign and female sex and higher NIHSS scores remain unclear but we speculate it could be mediated by differential distribution of stroke etiology or by chance.
It has been suggested that the angiographic occlusion appearance could influence the choice of EVT technique. Baik et al. found that in 161 patients with basilar artery occlusion, the use of contact aspiration as the primary thrombectomy technique in patients with meniscus sign was associated with shorter procedural time, lower number of maneuvers, higher frequency of first pass effect and higher frequency of complete reperfusion, when compared to the use of stent-retrievers [24]. Successful reperfusion was, however, not different between the two different primary techniques and clinical outcomes were similar. A recent study of patients with M1 and M2 occlusions showed better complete recanalization rates and better functional outcomes in patients with meniscus sign who had been treated with contact aspiration in comparison to stent-retriever [23]. Although contact aspiration technique in patients with meniscus sign was independently associated with complete recanalization, the analysis for the prediction of outcome was not adjusted for relevant co-variates in this study. The validity of these study results is also limited by the low number of patients with meniscus sign included (26 in 111 patients who underwent thrombectomy), and low number of patients with meniscus sign treated with each technique (14 with contact aspiration and 12 with stent-retriever). In our study we could not test the benefit of using stent-retriever versus contact aspiration in patients with meniscus sign, because only a residual number of patients were treated with the latter technique. It remains an open discussion if contact aspiration could provide better angiographic and clinical outcomes in patients with meniscus sign.
The main limitations of our study include the fact that we did not analyze other potential factors which are known to influence the success of EVT, namely anatomy and curvature of the occluded vessels, the clot burden and thrombus perviousness; however, because the meniscus sign was not associated with angiographic outcomes or clinical outcomes, it is unlikely that the adjustment of our analyses for these additional parameters would change our results significantly. The fact that the use of stent-retrievers was the primary technique of choice for the vast majority of patients in both centers did not allow to study the possible differential benefit of contact aspiration in patients with meniscus sign. Other limitations include missing information related to 3‑month outcome in 1/4 of the patients and incomplete etiological investigation in 7% of the patients. Our study also has significant strengths, namely the fact that it is based on prospective registries of stroke patients, that it is multicentric, that the population size is relatively large, and that assessment of the meniscus sign was blinded for angiographic and clinical outcomes.

Conclusion

The presence of meniscus sign in acute ischemic stroke patients with anterior circulation large vessel occlusion who undergo EVT with a stent-retriever technique does not appear to influence angiographic outcomes such as successful reperfusion and first pass effect, or clinical outcomes such as sICH and 3‑month functional outcome. The meniscus sign appears to be independently associated with cardioembolism, and this association warrants further studies.

Funding

The current study received no funding.

Conflict of interest

A. Miranda, R. Abdelnaby, A. Araújo, M. Rodrigues, V. Battistella, J.M. Roriz, C. Rodrigues, M. Wiesmann, J.B. Schulz, O. Nikoubashman, A. Reich, M. Ribeiro and J. Pinho declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Spiotta AM, Chaudry MI, Hui FK, Turner RD, Kellogg RT, Turk AS. Evolution of thrombectomy approaches and devices for acute stroke: a technical review. J Neurointerv Surg. 2015;7:2–7.CrossRefPubMed Spiotta AM, Chaudry MI, Hui FK, Turner RD, Kellogg RT, Turk AS. Evolution of thrombectomy approaches and devices for acute stroke: a technical review. J Neurointerv Surg. 2015;7:2–7.CrossRefPubMed
2.
Zurück zum Zitat Schwaiger BJ, Gersing AS, Zimmer C, Prothmann S. The curved MCA: influence of vessel anatomy on recanalization results of mechanical thrombectomy after acute ischemic stroke. AJNR Am J Neuroradiol. 2015;36:971–6.CrossRefPubMedPubMedCentral Schwaiger BJ, Gersing AS, Zimmer C, Prothmann S. The curved MCA: influence of vessel anatomy on recanalization results of mechanical thrombectomy after acute ischemic stroke. AJNR Am J Neuroradiol. 2015;36:971–6.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Dutra BG, Tolhuisen ML, Alves HCBR, Treurniet KM, Kappelhof M, Yoo AJ, Jansen IGH, Dippel DWJ, van Zwam WH, van Oostenbrugge RJ, da Rocha AJ, Lingsma HF, van der Lugt A, Roos YBWEM, Marquering HA, Majoie CBLM; MR CLEAN Registry Investigators†. Thrombus Imaging Characteristics and Outcomes in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment. Stroke. 2019;50:2057–64.CrossRefPubMed Dutra BG, Tolhuisen ML, Alves HCBR, Treurniet KM, Kappelhof M, Yoo AJ, Jansen IGH, Dippel DWJ, van Zwam WH, van Oostenbrugge RJ, da Rocha AJ, Lingsma HF, van der Lugt A, Roos YBWEM, Marquering HA, Majoie CBLM; MR CLEAN Registry Investigators†. Thrombus Imaging Characteristics and Outcomes in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment. Stroke. 2019;50:2057–64.CrossRefPubMed
4.
Zurück zum Zitat Santos EM, Marquering HA, den Blanken MD, Berkhemer OA, Boers AM, Yoo AJ, Beenen LF, Treurniet KM, Wismans C, van Noort K, Lingsma HF, Dippel DW, van der Lugt A, van Zwam WH, Roos YB, van Oostenbrugge RJ, Niessen WJ, Majoie CB; MR CLEAN Investigators. Thrombus Permeability Is Associated With Improved Functional Outcome and Recanalization in Patients With Ischemic Stroke. Stroke. 2016;47:732–41.CrossRefPubMed Santos EM, Marquering HA, den Blanken MD, Berkhemer OA, Boers AM, Yoo AJ, Beenen LF, Treurniet KM, Wismans C, van Noort K, Lingsma HF, Dippel DW, van der Lugt A, van Zwam WH, Roos YB, van Oostenbrugge RJ, Niessen WJ, Majoie CB; MR CLEAN Investigators. Thrombus Permeability Is Associated With Improved Functional Outcome and Recanalization in Patients With Ischemic Stroke. Stroke. 2016;47:732–41.CrossRefPubMed
5.
Zurück zum Zitat Tiedt S, Herzberg M, Küpper C, Feil K, Kellert L, Dorn F, Liebig T, Alegiani A, Dichgans M, Wollenweber FA; GSR Investigators. Stroke Etiology Modifies the Effect of Endovascular Treatment in Acute Stroke. Stroke. 2020;51:1014–6.CrossRefPubMed Tiedt S, Herzberg M, Küpper C, Feil K, Kellert L, Dorn F, Liebig T, Alegiani A, Dichgans M, Wollenweber FA; GSR Investigators. Stroke Etiology Modifies the Effect of Endovascular Treatment in Acute Stroke. Stroke. 2020;51:1014–6.CrossRefPubMed
6.
Zurück zum Zitat Liang W, Wang Y, Du Z, Mang J, Wang J. Intraprocedural angiographic signs observed during endovascular thrombectomy in patients with acute ischemic stroke. Neurology. 2021;96:1080–90.CrossRefPubMed Liang W, Wang Y, Du Z, Mang J, Wang J. Intraprocedural angiographic signs observed during endovascular thrombectomy in patients with acute ischemic stroke. Neurology. 2021;96:1080–90.CrossRefPubMed
7.
Zurück zum Zitat Baik SH, Kim JW, Kim BM, Kim DJ. Significance of angiographic clot meniscus sign in mechanical thrombectomy of basilar artery stroke. J Neurointerv Surg. 2020;12:477–82.CrossRefPubMed Baik SH, Kim JW, Kim BM, Kim DJ. Significance of angiographic clot meniscus sign in mechanical thrombectomy of basilar artery stroke. J Neurointerv Surg. 2020;12:477–82.CrossRefPubMed
8.
Zurück zum Zitat Mönch S, Boeckh-Behrens T, Berndt M, Maegerlein C, Wunderlich S, Zimmer C, Friedrich B. Angiographic Baseline Proximal Thrombus Appearance of M1/M2 Occlusions in Mechanical Thrombectomy. Clin Neuroradiol. 2021;31:189–96.CrossRefPubMed Mönch S, Boeckh-Behrens T, Berndt M, Maegerlein C, Wunderlich S, Zimmer C, Friedrich B. Angiographic Baseline Proximal Thrombus Appearance of M1/M2 Occlusions in Mechanical Thrombectomy. Clin Neuroradiol. 2021;31:189–96.CrossRefPubMed
9.
Zurück zum Zitat Turc G, Bhogal P, Fischer U, Khatri P, Lobotesis K, Mazighi M, Schellinger PD, Toni D, de Vries J, White P, Fiehler J. European Stroke Organisation (ESO)—European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE). Eur Stroke J. 2019;4:6–12.CrossRefPubMedPubMedCentral Turc G, Bhogal P, Fischer U, Khatri P, Lobotesis K, Mazighi M, Schellinger PD, Toni D, de Vries J, White P, Fiehler J. European Stroke Organisation (ESO)—European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE). Eur Stroke J. 2019;4:6–12.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Goyal M, Fargen KM, Turk AS, Mocco J, Liebeskind DS, Frei D, Demchuk AM. 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointerv Surg. 2014;6:83–6.CrossRefPubMed Goyal M, Fargen KM, Turk AS, Mocco J, Liebeskind DS, Frei D, Demchuk AM. 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointerv Surg. 2014;6:83–6.CrossRefPubMed
11.
Zurück zum Zitat Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Wolf ME, Hennerici MG. The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping). Cerebrovasc Dis. 2013;36:1–5.CrossRefPubMed Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Wolf ME, Hennerici MG. The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping). Cerebrovasc Dis. 2013;36:1–5.CrossRefPubMed
12.
Zurück zum Zitat Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, Cryptogenic Stroke/ESUS International Working Group, et al. Embolic strokes of undetermined source: the case for a clinical construct. Lancet Neurol. 2014;13:429–38.CrossRefPubMed Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, Cryptogenic Stroke/ESUS International Working Group, et al. Embolic strokes of undetermined source: the case for a clinical construct. Lancet Neurol. 2014;13:429–38.CrossRefPubMed
13.
Zurück zum Zitat von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE initiative. PLoS Med. 2007;4:e296. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE initiative. PLoS Med. 2007;4:e296.
14.
Zurück zum Zitat Meinel TR, Kaesmacher J, Chaloulos-Iakovidis P, Panos L, Mordasini P, Mosimann PJ, Michel P, Hajdu S, Ribo M, Requena M, Maegerlein C, Friedrich B, Costalat V, Benali A, Pierot L, Gawlitza M, Schaafsma J, Pereira VM, Gralla J, Fischer U. Mechanical thrombectomy for basilar artery occlusion: efficacy, outcomes, and futile recanalization in comparison with the anterior circulation. J Neurointerv Surg. 2019;11:1174–80.CrossRefPubMedPubMedCentral Meinel TR, Kaesmacher J, Chaloulos-Iakovidis P, Panos L, Mordasini P, Mosimann PJ, Michel P, Hajdu S, Ribo M, Requena M, Maegerlein C, Friedrich B, Costalat V, Benali A, Pierot L, Gawlitza M, Schaafsma J, Pereira VM, Gralla J, Fischer U. Mechanical thrombectomy for basilar artery occlusion: efficacy, outcomes, and futile recanalization in comparison with the anterior circulation. J Neurointerv Surg. 2019;11:1174–80.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis and treatment. Lancet Neurol. 2013;12:1106–14.CrossRefPubMedPubMedCentral Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis and treatment. Lancet Neurol. 2013;12:1106–14.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Meyer L, Fiehler J, Thomalla G, Krause LU, Lowens S, Rothaupt J, Kim BM, Heo JH, Yeo L, Andersson T, Kabbasch C, Dorn F, Chapot R, Stracke CP, Hanning U. Intracranial Stenting After Failed Thrombectomy in Patients With Moderately Severe Stroke: A Multicenter Cohort Study. Front Neurol. 2020;11:97.CrossRefPubMedPubMedCentral Meyer L, Fiehler J, Thomalla G, Krause LU, Lowens S, Rothaupt J, Kim BM, Heo JH, Yeo L, Andersson T, Kabbasch C, Dorn F, Chapot R, Stracke CP, Hanning U. Intracranial Stenting After Failed Thrombectomy in Patients With Moderately Severe Stroke: A Multicenter Cohort Study. Front Neurol. 2020;11:97.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Lee YY, Yoon W, Kim SK, Baek BH, Kim GS, Kim JT, Park MS. Acute Basilar Artery Occlusion: Differences in Characteristics and Outcomes after Endovascular Therapy between Patients with and without Underlying Severe Atherosclerotic Stenosis. AJNR Am J Neuroradiol. 2017;38:1600–4.CrossRefPubMedPubMedCentral Lee YY, Yoon W, Kim SK, Baek BH, Kim GS, Kim JT, Park MS. Acute Basilar Artery Occlusion: Differences in Characteristics and Outcomes after Endovascular Therapy between Patients with and without Underlying Severe Atherosclerotic Stenosis. AJNR Am J Neuroradiol. 2017;38:1600–4.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Consoli A, Rosi A, Coskun O, Nappini S, Di Maria F, Renieri L, Limbucci N, Rodesch G, Mangiafico S, Decroix JP, Kyheng M, Labreuche J, Lapergue B. Thrombectomy for M1-Middle Cerebral Artery Occlusion: Angiographic Aspect of the Arterial Occlusion and Recanalization: A Preliminary Observation. Stroke. 2018;49:1286–9.CrossRefPubMed Consoli A, Rosi A, Coskun O, Nappini S, Di Maria F, Renieri L, Limbucci N, Rodesch G, Mangiafico S, Decroix JP, Kyheng M, Labreuche J, Lapergue B. Thrombectomy for M1-Middle Cerebral Artery Occlusion: Angiographic Aspect of the Arterial Occlusion and Recanalization: A Preliminary Observation. Stroke. 2018;49:1286–9.CrossRefPubMed
19.
Zurück zum Zitat Garcia-Bermejo P, Patro SN, Ahmed AZ, Al Rumaihi G, Akhtar N, Kamran S, Salam A, Own A, Saqqur M, Shuaib A. Baseline Occlusion Angiographic Appearance on Mechanical Thrombectomy Suggests Underlying Etiology and Outcome. Front Neurol. 2019;10:499.CrossRefPubMedPubMedCentral Garcia-Bermejo P, Patro SN, Ahmed AZ, Al Rumaihi G, Akhtar N, Kamran S, Salam A, Own A, Saqqur M, Shuaib A. Baseline Occlusion Angiographic Appearance on Mechanical Thrombectomy Suggests Underlying Etiology and Outcome. Front Neurol. 2019;10:499.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Pillai JJ, Lanzieri CF, Trinidad SB, Tarr RW, Sunshine JL, Lewin JS. Initial angiographic appearance of intracranial vascular occlusions in acute stroke as a predictor of outcome of thrombolysis: initial experience. Radiology. 2001;218:733–8.CrossRefPubMed Pillai JJ, Lanzieri CF, Trinidad SB, Tarr RW, Sunshine JL, Lewin JS. Initial angiographic appearance of intracranial vascular occlusions in acute stroke as a predictor of outcome of thrombolysis: initial experience. Radiology. 2001;218:733–8.CrossRefPubMed
21.
Zurück zum Zitat Berndt M, Friedrich B, Maegerlein C, Moench S, Hedderich D, Lehm M, Zimmer C, Straeter A, Poppert H, Wunderlich S, Schirmer L, Oberdieck P, Kaesmacher J, Boeckh-Behrens T. Thrombus Permeability in Admission Computed Tomographic Imaging Indicates Stroke Pathogenesis Based on Thrombus Histology. Stroke. 2018;49:2674–82.CrossRefPubMed Berndt M, Friedrich B, Maegerlein C, Moench S, Hedderich D, Lehm M, Zimmer C, Straeter A, Poppert H, Wunderlich S, Schirmer L, Oberdieck P, Kaesmacher J, Boeckh-Behrens T. Thrombus Permeability in Admission Computed Tomographic Imaging Indicates Stroke Pathogenesis Based on Thrombus Histology. Stroke. 2018;49:2674–82.CrossRefPubMed
22.
Zurück zum Zitat Santos EM, Dankbaar JW, Treurniet KM, Horsch AD, Roos YB, Kappelle LJ, Niessen WJ, Majoie CB, Velthuis B, Marquering HA; DUST Investigators. Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke. Stroke. 2016;47:2058–65.CrossRefPubMed Santos EM, Dankbaar JW, Treurniet KM, Horsch AD, Roos YB, Kappelle LJ, Niessen WJ, Majoie CB, Velthuis B, Marquering HA; DUST Investigators. Permeable Thrombi Are Associated With Higher Intravenous Recombinant Tissue-Type Plasminogen Activator Treatment Success in Patients With Acute Ischemic Stroke. Stroke. 2016;47:2058–65.CrossRefPubMed
23.
Zurück zum Zitat Nie C, Kang Z, Tu M, Wu X, Sun D, Mei B. Clot meniscus sign is associated with thrombus permeability and choice of mechanical thrombectomy technique in acute middle cerebral artery occlusion. Front Neurol. 2022;13:850429.CrossRefPubMedPubMedCentral Nie C, Kang Z, Tu M, Wu X, Sun D, Mei B. Clot meniscus sign is associated with thrombus permeability and choice of mechanical thrombectomy technique in acute middle cerebral artery occlusion. Front Neurol. 2022;13:850429.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Baik SH, Jung C, Kim BM, Han K, Kim DJ. Clot meniscus sign: an angiographic clue for choosing between stent retriever and contact aspiration in acute basilar artery occlusion. AJNR Am J Neuroradiol. 2021;42:732–7.CrossRefPubMedPubMedCentral Baik SH, Jung C, Kim BM, Han K, Kim DJ. Clot meniscus sign: an angiographic clue for choosing between stent retriever and contact aspiration in acute basilar artery occlusion. AJNR Am J Neuroradiol. 2021;42:732–7.CrossRefPubMedPubMedCentral
Metadaten
Titel
Meniscus Sign in Patients with Anterior Circulation Large Vessel Occlusion Stroke does not Predict Outcome
verfasst von
André Miranda
Ramy Abdelnaby
André Araújo
Marta Rodrigues
Valeria Battistella
José Mário Roriz
Carmélia Rodrigues
Martin Wiesmann
Jörg B. Schulz
Omid Nikoubashman
Arno Reich
Manuel Ribeiro
João Pinho
Publikationsdatum
24.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 1/2023
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-022-01183-w

Weitere Artikel der Ausgabe 1/2023

Clinical Neuroradiology 1/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.